- Investing Ideas
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
16
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
16 companies
Ascendis Pharma
Market Cap: US$13.4b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$215.54
7D
-5.5%
1Y
33.8%
Madrigal Pharmaceuticals
Market Cap: US$10.3b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$445.04
7D
0.4%
1Y
29.6%
Insmed
Market Cap: US$31.0b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$139.14
7D
-3.3%
1Y
77.2%
Alnylam Pharmaceuticals
Market Cap: US$40.7b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$308.05
7D
-3.9%
1Y
9.6%
BeOne Medicines
Market Cap: US$30.5b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$275.69
7D
-4.1%
1Y
10.1%
BridgeBio Pharma
Market Cap: US$13.5b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$68.53
7D
-3.4%
1Y
86.5%
Ionis Pharmaceuticals
Market Cap: US$11.7b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$69.68
7D
-3.7%
1Y
115.9%
AbbVie
Market Cap: US$362.4b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$205.20
7D
-6.6%
1Y
1.9%
Jazz Pharmaceuticals
Market Cap: US$11.2b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$185.01
7D
2.0%
1Y
36.8%
Eli Lilly
Market Cap: US$814.8b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$903.02
7D
-2.9%
1Y
5.9%
BioMarin Pharmaceutical
Market Cap: US$10.5b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$54.09
7D
-3.5%
1Y
-24.4%
Natera
Market Cap: US$28.4b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$194.52
7D
-1.9%
1Y
25.8%
Viatris
Market Cap: US$15.3b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$13.36
7D
-3.2%
1Y
49.3%
Royalty Pharma
Market Cap: US$26.3b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$45.57
7D
-1.2%
1Y
35.0%
Elanco Animal Health
Market Cap: US$12.2b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$24.90
7D
-1.1%
1Y
136.9%
Waters
Market Cap: US$29.6b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$301.92
7D
1.7%
1Y
-18.1%